| Chelsea Nicole Kelley, | |
|
302 Lakeview Dr, Dothan, AL 36301-2438 | |
| (334) 714-7778 | |
| Not Available |
| Full Name | Chelsea Nicole Kelley |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 302 Lakeview Dr, Dothan, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093401804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1-172810 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Nicole Kelley, 302 Lakeview Dr, Dothan, AL 36301-2438 Ph: (334) 714-7778 | Chelsea Nicole Kelley, 302 Lakeview Dr, Dothan, AL 36301-2438 Ph: (334) 714-7778 |
News Archive
QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.
Heartburn is a signature symptom of gastroesophageal reflux disease (GERD), which is a cluster of symptoms and signs associated with regurgitation of stomach acid up to the pharynx and mouth. Patient-based studies of GERD have shown high prevalence and chronicity, particularly in Western societies. GERD is associated with significant health-care utilization and diminished quality of life.
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.
A QUT scientist is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain.
Silence Therapeutics plc today announced that the company and Dainippon Sumitomo Pharma Co., Ltd. have agreed to an expansion of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in August 2009, the companies are leveraging Silence's proprietary siRNA molecules and multiple lipid delivery and targeting technologies to demonstrate functional delivery of RNA interference (RNAi) therapeutics to specific disease targets in the body.
› Verified 8 days ago
Bethany Makayla Gilman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1108 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-8111 | |
Pamela Galloway, RN, CLC, DOULA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 799 Burkett Rd, Dothan, AL 36303 Phone: 334-798-3323 | |
Mrs. Diana Phelps Golson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 134 Prevatt Rd, Dothan, AL 36301 Phone: 334-794-0731 | |
Pamela Rose Wilder, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 4370 W Main St, Dothan, AL 36305 Phone: 334-793-5000 | |
Mrs. Robin Gay Quire, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 134 Prevatt Rd, Dothan, AL 36301 Phone: 334-794-0731 | |
Mr. Jason Lee Cox, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St Ste 21, Dothan, AL 36305 Phone: 334-699-7900 |